Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Authors
Keywords
TNBC, Human antibody-based therapy, Immunomodulation, Protease, Tumor microenvironment, Phage display
Journal
Journal for ImmunoTherapy of Cancer
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-04
DOI
10.1186/s40425-019-0498-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cathepsin D non-proteolytically induces proliferation and migration in human omental microvascular endothelial cells via activation of the ERK1/2 and PI3K/AKT pathways
- (2018) Md Zahidul I. Pranjol et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer
- (2017) Muhammad Tariq et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis
- (2017) Elham Safarzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide
- (2017) Pablo Scodeller et al. Scientific Reports
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
- (2016) Anna-Maria Georgoudaki et al. Cell Reports
- Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast cancers
- (2015) Hasitha Shilpa Anantaraju et al. MOLECULAR DIVERSITY
- FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities
- (2015) Falk Nimmerjahn et al. TRENDS IN IMMUNOLOGY
- Unraveling the molecular architecture of a G protein-coupled receptor/β-arrestin/Erk module complex
- (2015) Thomas Bourquard et al. Scientific Reports
- Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancer
- (2014) Haïdar Saadoun et al. Future Oncology
- Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment
- (2013) MARIE MAYNADIER et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse
- (2013) Stanislas du Manoir et al. Molecular Oncology
- A Prognostic Model for Triple-Negative Breast Cancer Patients Based on Node Status, Cathepsin-D and Ki-67 Index
- (2013) Liang Huang et al. PLoS One
- Current advances in humanized mouse models
- (2012) Ryoji Ito et al. Cellular & Molecular Immunology
- Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment
- (2012) Valérie Laurent-Matha et al. FASEB JOURNAL
- Generation and Comparative Characterization of Glycosylated and Aglycosylated Human IgG1 Antibodies
- (2012) Dmitrij Hristodorov et al. MOLECULAR BIOTECHNOLOGY
- TGF-β-induced epithelial-mesenchymal transition: A link between cancer and inflammation
- (2012) Jonas Fuxe et al. SEMINARS IN CANCER BIOLOGY
- Innovative Proteomics for the Discovery of Systemically Accessible Cancer Biomarkers Suitable for Imaging and Targeted Therapies
- (2011) Andrei Turtoi et al. AMERICAN JOURNAL OF PATHOLOGY
- Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis
- (2011) D Derocq et al. ONCOGENE
- Interleukin-15 biology and its therapeutic implications in cancer
- (2011) Jason C. Steel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?
- (2010) Olivier Masson et al. BIOCHIMIE
- Pro-cathepsin D interacts with the extracellular domain of the chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth
- (2010) M. Beaujouin et al. JOURNAL OF CELL SCIENCE
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Cathepsin D—Many functions of one aspartic protease
- (2008) Petr Benes et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started